During the past decade, Alegent Creighton Health conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 7 clinical trials were completed, i.e. on average, 87.5% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 6 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Alegent Creighton Health" #1 sponsor was "Abbott Medical Devices" with 2 trials, followed by "Exact Sciences Corporation" with 2 trials sponsored, "Gilead Sciences" with 2 trials sponsored, "Boston Scientific Corporation" with 1 trials sponsored and "Brigham and Women's Hospital" with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Alegent Creighton Health" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator, "Pharmaceutical Research Associates" with 1 trials as a collaborator and "Triangle Biostatistics" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Alegent Creighton Health" are "Colorectal Cancer" (2 trials), "Adverse Effect of MRI on an Implanted Pacemaker" (1 trials), "Adverse Effect of MRI on an Implanted Pacemaker Lead" (1 trials), "Atrial Fibrillation" (1 trials) and "Bacterial Vaginosis" (1 trials). Many other conditions were trialed in "Alegent Creighton Health" in a lesser frequency.

Most popular intervention types in "Alegent Creighton Health" are "Drug" (9 trials), "Device" (2 trials), "Other" (2 trials), "Biological" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "1% SPL7013 Gel" (1 trials), "Accent MRI system (lead safety)" (1 trials), "Accent MRI system (with MRI scan)" (1 trials) and "Anti-HBV nucleoside/nucleotide therapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "Alegent Creighton Health" are 13 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Alegent Creighton Health". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Alegent Creighton Health, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Alegent Creighton Health, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".